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Ananya Majumdarl, Weijun Xul, George McLendon*, Andrew Ellington3 
and Dinshaw J Patell 
Background: The biological function of several viral and bacteriophage 
proteins, and their arginine-rich subdomains, involves RNA-mediated 
interactions. It has been shown recently that bound peptides adopt either 
P-hairpin or a-helical conformations in viral and phage peptide-RNA complexes. 
We have compared the structures of the arginine-rich peptide domain of HIV-1 
Rev bound to two RNA aptamers to determine whether RNA architecture can 
dictate the conformations of a bound peptide. 
Results: The core-binding segment of the HIV-1 Rev peptide class II RNA 
aptamer complex spans the two-base bulge and hairpin loop of the bound RNA 
and the carboxy-terminal segment of the bound peptide. The bound peptide is 
anchored in place by backbone and sidechain intermolecular hydrogen bonding 
and van der Waals stacking interactions. One of the bulge bases participates in 
U*(A*U) base triple formation, whereas the other is looped out and flaps over the 
bound peptide in the complex. The seven-residue hairpin loop is closed by a 
sheared G*A mismatch pair with several pyrimidines looped out of the hairpin fold. 
Conclusions: Our structural studies establish that RNA architecture dictates 
whether the same HIV-1 Rev peptide folds into an extended or a-helical 
conformation on complex formation. Arginine-rich peptides can therefore adapt 
distinct secondary folds to complement the tertiary folds of their RNA targets. 
This contrasts with protein-RNA complexes in which elements of RNA 
secondary structure adapt to fit within the tertiary folds of their protein targets. 
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Introduction 
The regulation of the lentiviral replication cycle is con- 
trolled by the RNA-binding Tat (trans-activator protein) 
and Rev (regulator of viral expression) proteins [1,2]. The 
HIV-l Rev protein binds to the Rev response element 
(RRE) RNA located within the transcript of the ena (enve- 
lope) gene [3-S] and mediates the export of intron-con- 
taining messenger RNAs that encode viral structural 
proteins to the cytoplasm. There is considerable interest 
in elucidating the structure of the complex between the 
HIV-l Rev protein and its high affinity RRE RNA target 
as a prelude to the structure-based design of inhibitors 
that could interfere with this process, which is critical for 
the maintenance of the viral life cycle. 
The HIV-l Rev-RRE system has been approached bio- 
chemically by investigating its modular interacting compo- 
nents [6,7]. We know that an arginine-rich basic peptide 
segment of HIV-l Rev extending from residues Thr34- 
ArgSO (Figure la) binds to the stem-loop IIB domain of 
the RRE RNA with nanomolar affinity and high specificity 
[8]. Solution structures are available for this complex [9] 
and a related complex [lo] of the basic Rev peptide with 
an RNA aptamer [ 1 l] (Figure lc) that is a higher-affinity 
binding variant of stem-loop IIB RRE RNA. The Rev 
peptide undergoes an adaptive transition to an a-helical 
conformation [12] and penetrates deeply into the major 
groove of the RNA centered around a zippered up asym- 
metric internal bubble in both complexes [9,10]. 
Two distinct families of RNA aptamers have been iden- 
tified that target the arginine-rich HIV-l Rev peptide 
(Figure la) with high specificity and nanomolar affinity. 
One of these, designated 35-mer RNA aptamer I 
(family I), has a secondary structure [l l] that contains an 
asymmetric internal loop binding site (Figure lc) analo- 
gous to the stem-loop IIB of the RRE RNA. The other 
family, designated 27-mer RNA aptamer II (family II), 
has a very different secondary structure [13] composed 
of a seven-residue hairpin loop and a two-base bulge 
(Figure lb). The availability of two RNA aptamers that 
are targeted by a common HIV-l Rev peptide should 
allows us to address the following fundamental question 
related to adaptive structural transitions of arginine-rich 
peptides [14] targeted to binding pockets associated 
with RNA tertiary structure. Does the bound Rev 
peptide adopt similar conformations on both RNA 
aptamer targets or does it adopt different folds defined 
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(a) Sequence and numbering of HIV-1 17-mer Rev peptide (using (0.6-4.8 ppm) of the bound RNA in the 17-mer Rev peptide-27-mer 
single-letter amino acid code). Sequence, secondary structure and RNA aptamer II complex in H,O buffer, pH 6.2 at 10°C. The labeled 
numbering of (b) the 27-mer RNA aptamer II used in this study and cross peaks involve intermolecular NOES between the imino protons 
(c) the 35-mer RRE RNA aptamer I studied previously [lo]. (d) An of GlO, U7, G21 and U16 of the bound RNA aptamer and the Ho, 
expanded NOESY contour plot outlining NOES between imino protons HP, Hy and H6 protons of Trp45, Arg46, Gl1.147 and Arg48 of the 
(9.6 to 12.0 ppm) and amino acid Ha and sidechain protons bound Rev peptide. 
by potentially distinct binding-pocket architectures asso- 
ciated with the two classes of RNA aptamer targets? 
We report below on the solution structure of the 17-mer 
HIV-l Rev peptide bound to the 27-mer RNA aptamer II 
elucidated using a combination of nuclear magnetic reso- 
nance (NMR) and computational approaches. This struc- 
ture is compared with the structure of the 17-mer HIV-1 
Rev peptide bound to the 35mer RNA aptamer I 
reported previously [lo]. Our studies establish that the 
same HIV-l Rev peptide adopts an extended conforma- 
tion in the complex with an RNA aptamer of class II type 
(Figure 2b; this study), whereas it has an a-helical confor- 
mation [9,10,12] in the complex with an RNA aptamer of 
class I type (Figure Za) [lo]. These studies establish that 
the same peptide can undergo adaptive structural transi- 
tions to distinct bound conformations dependent on the 
binding-pocket architecture of the RNA target. 
Results 
Complex formation 
The solution structure of the 17-mer HIV-l Rev peptide 
complexed to the 27-mer RNA aptamer II (Figure lb) was 
characterized using multidimensional heteronuclear NMR 
spectroscopy [1.5-171. We have recorded the exchangeable 
proton spectra (8.5-14.5 ppm) of the free RNA aptamer on 
gradual addition of one equivalent of Rev peptide in Hz0 
buffer, pH 6.2 at 10°C. Imino proton resonances from both 
the free RNA aptamer and the complex were observed on 
substoichiometric addition of the Rev peptide, consistent 
with slow exchange between the free and bound forms and 
reflective of the high affinity associated with complex forma- 
tion. The observation of a unique set of imino proton reso- 
nances of the bound RNA between 10 and 14 ppm and a 
unique set of amide proton resonances of the bound Rev 
peptide between 8.5 and 10.0 ppm is indicative of a predom- 
inant peptide-RNA conformation on complex formation. 
We also generated complexes of the 17-mer Rev peptide 
with two additional RNA aptamers in the same class II 
family [ 131 and recorded their NMR spectra. The secondary 
folds of 29-mer RNA aptamer II and 36-mer RNA 
aptamer II differed from the 27-mer RNA aptamer II in the 
number of base pairs separating the common two-base 
bulge and 7-mer hairpin loop segments. Most importantly, 
they differed in the residues at positions 13 and 15 of the 
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Figure 2 
A comparison of representative refined 
structures of the complexes of the HIV-1 
17-mer Rev peptide with (a) the 35-mer RRE 
RNA aptamer I (Figure 1 c) reported previously 
[lo] and (b) the 27-mer RNA aptamer II 
(Figure 1 b) reported in this study. The peptide 
backbones are represented by yellow ribbons 
with key sidechains in orange. The RNAs are 
white, backbone phosphorus atoms are red, 
base mismatches are pink and base triples are 
cyan. The peptide backbone adopts an 
a-helical fold in (a) and is extended in (b). 
RNA hairpin loop and were therefore of considerable help 
in the spectral assignments of these residues, and other 
residues in overlap regions of the two-dimensional data sets. 
The 17-mer HIV-l Rev peptide contains ten arginine 
residues, and one challenge was to identify and distin- 
guish between these amino acids with their long 
sidechains in the spectra of the complex. We therefore 
also generated and recorded NMR spectra for complexes 
of the 27-mer RNA aptamer II with analogs of the 17-mer 
Rev peptide containing amino-acid substitutions and/or 
deletions. These included a 1.5mer peptide lacking the 
last two residues and Arg39+Ala (R39A) and Arg44+Asn 
(R44N) substitutions, and an 11-mer peptide lacking the 
first six residues and Arg42+Ala (R42A) and Arg43+Ala 
(R43A) substitutions. Both these mutant and truncated 
Rev peptides bound the Z7-mer RNA aptamer II under 
slow-exchange conditions with spectra that corresponded 
to a predominant conformation for the complex. 
Structure determination 
The solution structure of the HIV-l 17-mer Rev peptide- 
27-mer RNA aptamer II complex was characterized using 
multidimensional NMR spectroscopy. Resonances from 
the bound RNA were assigned from the sample containing 
uniformly 13C,i5N-labeled 27-mer RNA, and augmented 
where necessary with complexes generated with unlabeled 
29-mer and 36mer RNA aptamer II analogs. Resonances 
from the bound Rev peptide were assigned from samples 
containing unlabeled and uniformly 13C,i5N-labeled 
17-mer peptide, selectively 13C,1SN-labeled (at Arg41 and 
Arg45) 17-mer peptide, and augmented where necessary 
with complexes generated with unlabeled 15mer and 
11-mer peptide analogs. 
We identified 49 intermolecular nuclear Overhauser 
effects (NOES) between the 17-mer Rev peptide and the 
27-mer RNA aptamer II in the complex (Table 1). Several 
of these intermolecular NOES involve RNA-aptamer- 
exchangeable imino protons and examples of these 
between the imino protons of GlO, U7, G21 and U16 and 
nonexchangeable arginine sidechain protons are shown in 
an expanded NOESY contour plot of the complex in Hz0 
buffer at 10°C (Figure Id). The majority of these NOES 
span the Arg39-Arg48 segment of the bound Rev peptide 
and the U7-C20 segment of the bound RNA aptamer. 
The largest number of intermolecular NOES involve the 
peptide sidechains of Arg41 and Trp45 and the RNA base 
and sugar protons of U16 in the complex (Table 1). Of 
specific interest are the intermolecular NOES between 
the sidechain of Arg41 and the RNA U7 and GlO residues 
and between the sidechains of the Trp45-Arg46- 
Glu47-Arg48 segment and the RNA U16 residue in the 
complex (Table 1). We did not detect intermolecular 
NOES involving assigned arginine sidechain NH& protons 
in the complex, possibly because of the increased line 
width of these exchangeable resonances (Table 1). We 
were unable to assign any arginine sidechain NH,q 
protons because of increased line widths and resonance 
overlap, and were not, therefore, in a position to monitor 
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Table 1 Table 2 
Intermolecular NOEs in the 17.mer Rev peptide-27-mer RNA 
aptamer complex. 
Amino acid Nucleotide 
Thr34 9-b U3 (H5, H6) 
Ala37 W-4 U5 (H5, H6) 
Arg38 SCH, U5 (H5) 
Arg39 W-6, Y-3 U19 (H5) 
6CH, U 19 (H5), C20 (H5) 
Asn40 P’W U19 (H5) 
6NH, G5 (HE), G6 (HE) 
Arg41 W-4 U7(NH3, H5) 
Q-6 GlO (NHl), U7 (NH3, H5), U19 (NH3) 
6CH, GlO (NHl), U7 (NH3, H5), U8 (H5) 
Arg44 6CH, UE(H1’) 
Trp45 CH6, U16 (NH3) 
CHE, U16 (NH3, Hl’, H2”, H3’) 
0% U16 (NH3, H5) 
CHC, U16 (H5, Hl’, H2”, H3’) 
Arg46 NH, PCH,, W-$ U16 (NH3) 
SCH, U16 (NH3, Hl’) 
Glu47 NH U16 (NH3) 
Arg48 NH U16 (NH3) 
PC& =H,, U16 (NH3), U13 (H5) 
Restraints and refinement statistics for the HIV-1 Rev peptide- 
RNA aptamer complex. 
NMR restraints in complex 
RNA (G 1 -C27) 
RNA distance restraints 204 
Peptide (Thr34-Arg50) 
Peptide distance restraints 107 
Peptide-RNA 
Intermolecular distance restraints 49 
Structure statistics in complex 
NOE violations 
Number > 0.2 8, 2.7 + 0.9 
Maximum violations (A) 0.38 f 0.01 
rmsd of violations (A) 0.039 f 0.002 
Deviations from the ideal covalent geometry 
Bond length (A) 0.016 f 0.0001 
Bond angle (“) 2.25 f 0.031 
Impropers (“) 0.63 k 0.08 
Pairwise rmsd (A) among 22 refined structures (all heavy atoms) 
Core complex: RNA (U7-G21) and peptide 
(Asn40-Arg48, backbone and sidechains) 2.79 f 0.47 
Core complex: RNA (U7-U8, Gl O-G1 2, G14 
and U16-G21) and peptide (Asn40-Arg48, 
backbone only) 1.55 f 0.38 
intermolecular NOES involving these exchangeable 
protons in the complex. 
The solution structure of the 17-mer Rev peptide-27- 
mer-RNA aptamer II complex was solved using molecular 
dynamics computations guided by NOE distance 
restraints. We generated 60 starting structures with both 
the peptide and RNA in randomized alignments and posi- 0 
tioned far apart (separated by 100 A). The helical stem 
extending from Gl-C6 and from GZZ-CZ7 outside the 
core-binding region was restricted to an A-helical confor- 
mation by dihedral angle and hydrogen-bond restraints 
during the computations. In addition, hydrogen-bonding 
restraints were used to restrain the experimentally identi- 
fied sheared GlZ*A18 mismatch alignment within the 
core-binding region in the complex. The protocol out- 
lined in the Materials and methods section involved initial 
torsional space dynamics at 20,000 K followed by Cartesian 
space dynamics at 300 K. A subset of 22 refined structures 
of the complex were identified based on low NOE viola- 
tion energies and exhibit a pairwise root mean square 
deviation (rmsd) value of 2.79 A? 0.47 for the central 
core-binding region of the complex (RNA U7-G21 and 
peptide Asn40-Arg48; Table 2). This high rmsd value 
reflects our inability to precisely define the majority of 
the sidechains (in contrast to the better defined back- 
bone) of the bound peptide and the G9, U13 and Cl5 
looped out residues of the bound RNA aptamer in the 
core-binding region of the complex. The pairwise rmsd 
value of the complex decreases to 1.55 A f 0.38 for the 
core-binding region comprising well-defined U7-U8, 
GIO-G12, G14 and U16-G21 RNA residues and back- 
bone atoms only for the Asn40-Arg48 segment of the 
peptide in the complex (Table 2). 
Structure analysis 
A stereo view of eight superpositioned distance-refined 
structures of the core-binding region of the HIV-l Rev 
peptide-RNA aptamer II complex looking normal to the 
helix axis and into the major groove is shown in 
Figure 3a. Stick and space-filling views of a representa- 
tive refined structure of the core-binding region of the 
complex including peptide sidechains are shown in 
Figure 3b,c. The Asn40-Arg48 segment of the Rev 
peptide binds in an extended conformation to the major 
groove of the bulge-containing stem segment and 
attached hairpin-loop segment extending from U7-G21 
of the RNA aptamer. The intermolecular contacts in the 
refined structures of the HIV-l Rev peptide-RNA 
aptamer II complex, along with their counterparts in the 
refined structures of the HIV-l Rev peptide-RNA 
aptamer I complex published previously [lo], are summa- 
rized schematically in Figure 4. 
Eight superpositioned and one representative refined 
structure of the seven-residue hairpin loop extending 
from G12-A18 of the bound RNA aptamer in the 
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Figure 3 
(a) A stereo view of eight superpositioned 
refined structures of the 17-mer Rev 
peptide-27-mer RNA aptamer II complex. The 
peptide backbones without sidechains from 
residues Asn40-Arg48 are shown in yellow. 
The RNA aptamers are shown from residues 
U7-G21. The backbone is orange, the base 
and sugar rings are blue except for the 
sheared G12*A18 mismatch, which is red, 
and the U8*(All *t-t1 9) triple, which is green. 
(b) Stick and (c) space-filling views of one 
representative structure of the 17-mer Rev 
peptide-27-mer RNA aptamer complex. The 
sidechains of the bound peptide are included 
in this view. The components of the complex 
and the color coding are the same as in (a). 
complex are shown in Figure Sa,b, respectively. These 
views emphasize which residues of the bound RNA 
hairpin loop are well defined in the refined structures of 
the complex. Eight superpositioned and one representa- 
tive refined structure of the Trp4.5-Arg48 segment of the 
bound Rev peptide in the complex are shown in 
Figure Sc,d. These views emphasize that the peptide 
backbone and Trp45 sidechain are better defined than 
the sidechains of Arg46, Glu47 and Arg48, amongst the 
refined structures of the complex. 
Several patterns of intermolecular interactions can be 
identified at the interface between the Rev peptide and 
the RNA aptamer within the core-binding segment of the 
complex. The orientations of the Trp45 and Arg48 
sidechains of the Rev peptide relative to the G14 and U16 
bases at the tip of the RNA hairpin loop in the complex 
are shown in Figure 6a,b. The interaction between the 
Watson-Crick edge of U16 at the tip of the RNA hairpin 
loop and the peptide backbone of residues Arg46 and 
Arg48 in the complex are shown in Figure 6c,d. Also 
shown is the orientation of the sidechain of Arg46 relative 
to the RNA backbone on either side of G12. The align- 
ment of the Arg41 sidechain of the Rev peptide relative to 
the major groove edge of GlO and their positioning next to 
the buckled U8*(All*U19) base triple in the complex are 
shown in Figure 6e,f. 
Discussion 
Quality of refined structures 
We have not been able to determine a high-resolution 
structure of the entire HIV-l 17-mer Rev peptide-27-mer 
RNA aptamer II complex because of the less than optimal 
quality of the NMR data sets. Our structure determination 
was handicapped by severe overlap of Ha and sidechain 
proton resonances of the bound Rev peptide that could 
only be partially overcome with two-dimensional and 
three-dimensional experiments on samples of the complex 
labeled with uniformly lSN-labeled and 13C,15N-labeled 
peptide. Several of the peptide protons in the complex 
were also broader than others, further complicating the 
spectral analysis. These limitations were reflected in our 
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Schematic summaries of structural features and intermolecular contacts 
(indicated by arrows) in the solution structures of (a) the 35-mer RRE 
RNA aptamer I (Figure 1 c) reported previously [I 01 and (b) the 27-mer 
RNA aptamer II (Figure 1 b) reported in this study. Bases are 
represented by rectangles, sugars by pentagons and phosphate groups 
by small circles. The amino acids involved in specificity-determining 
intermolecular interactions are enclosed in ovals. 
inability to define precisely the majority of the peptide 
sidechains in the core-binding segment of the complex. 
There was also severe overlap of RNA sugar resonances of 
the stem segment (Gl-C6 and GZZ-(227) in the complex. 
This required the inclusion of torsional and hydrogen- 
bonding restraints to define this helical segment located 
outside the core-binding region of the complex during the 
computations. Our structural analysis and subsequent dis- 
cussion of the core-binding segment of the HIV-l Rev 
peptide-RNA aptamer complex will, therefore, focus 
solely on those aspects of the structure that are unambigu- 
ously defined and merit further consideration. 
Alignment of the Rev peptide within the RNA aptamer 
binding pocket 
The 17-mer Rev peptide binds within the RNA major 
groove on complex formation, with the binding site 
spanning the helical and hairpin loop segments of the 
27-mer RNA aptamer II. The carboxyl terminus of the 
Rev peptide is directed towards the hairpin loop with 
the best defined interface spanning the As&O-Arg48 
segment of the 17-mer peptide and U7-G21 segment of 
the 27-mer RNA aptamer II (Figure 3a). The RNA and 
peptide backbone are better defined than the peptide 
sidechains within this core-binding segment of the 
complex. The peptide in an extended conformation is 
embedded within the walls of the major groove of the 
stem and adjacent hairpin loop (Figure 3b), with several 
sequence and structure specific intermolecular contacts 
within the core-binding segment (Figure 4b) contribut- 
ing to the specificity and affinity of complex formation. 
Adaptive conformational transitions on complex formation 
Both the Rev peptide and the RNA aptamer undergo 
adaptive conformational transitions on complex formation. 
This is readily apparent from changes in the NMR spectra 
of the exchangeable proton region where new imino reso- 
nances are observed between 9.5 and 10.5 ppm after the 
free RNA aptamer is converted to a complex with the Rev 
peptide. We also observe distinct amide proton chemical 
shifts between 8.5 and 10.0 ppm for the bound Rev 
peptide on complex formation. 
The free Rev peptide has been shown to be predomin- 
antly unstructured (~10% a helicity by circular dichroism 
[12]) in solution and probably rapidly interconverts 
between an ensemble of unstructured states. By contrast, 
the same Rev peptide, when bound to a class II RNA 
aptamer, adopts a unique extended conformation. The 
distinct extended conformation reflects the linear thread- 
ing of the peptide through the RNA recognition pocket. 
Structural features of the bulge residues in the bound RNA 
The U8 and G9 bulge residues are separated from the 
seven-residue hairpin loop by two Watson-Crick base 
pairs in the secondary fold of the RNA aptamer II 
(Figure 1 b). These two bulge residues make a critical con- 
tribution to the generation of the peptide-binding pocket 
on the RNA. G9 adopts an alignment with its purine ring 
approximately parallel to the helix axis. G9 acts as a flap 
and makes an important contribution to anchoring the 
peptide within the walls of the major groove (Figure 3b). 
By contrast, the U8 bulge base participates in a 
US(All*U19) base triple alignment on complex forma- 
tion. The resulting stacking of the U&(All*U19) base 
triple over the GlO*CZO base pair is consistent with the 
observed nonsequential NOE between H8 proton of GlO 
and the Hl’ proton of U8 in the complex. The defined 
positioning of the U8 and G9 bulge residues is accompa- 
nied by an S-shaped fold for the U7-US-G9-GlO segment 
of the RNA backbone, which is accompanied by mutual 
stacking of the junctional base pairs of the adjacent stem 
segments on complex formation. 
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Figure 5 
Views of (a& eight superpositioned refined 
structures and (b,d) one representative 
refined structure of particular segments of the 
17-mer Rev peptide-27-mer RNA aptamer II 
complex. (a,b) The bound RNA segment from 
G12-A18. This view emphasizes the potential 
intermolecular hydrogen-bonding interaction 
between donor hydrogens along the 
Watson-Crick edge of G17 and the 
phosphate oxygens at the G12-U13 step 
(phosphorus in red). Note that G14 is partially 
sandwiched between U13 and U16 within the 
loop segment of the complex. (c,d) The bound 
peptide segment from Trp45-Arg48. Certain 
amino acid sidechains (Trp45) are better 
defined than others (Arg46). 
U8-(All419) base triple in bound RNA 
The U8 is positioned in the major groove and is inclined 
relative to the Watson-Crick All*U19 pair on formation of 
the U&(Al l*U19) base triple amongst the distance refined 
structures of the complex (Figure 6e). Our inability to pre- 
cisely define the position of U8 originates in the availabil- 
ity of limited markers on this residue because the base H5 
and H6 protons are broad and we have been unable to 
assign the imino proton of U8 in the spectrum of the 
complex. It is interesting that well-defined approximately 
planar U*(A*U) triples have been identified for the bovine 
immunodeficiency virus (BIV) Tat peptide-TAR RNA 
[18] and HIV-l Rev peptide-RNA aptamer I [lo] com- 
plexes, where the third-strand uracil imino proton could be 
assigned and its alignment along the Hoogsteen edge of 
the adenine could be defined by an NOE between its 
imino proton and the H8 proton of the adenine [10,18]. By 
contrast, buckled U*(A*U) triples have been proposed for 
argininamide-HIV-l TAR [19,20], argininamide-HIV-2 
TAR [Zl] and HIV-l Tat peptide-TAR RNA [19,20] com- 
plexes, where the third strand uracil imino proton could 
not be identified in the spectrum of the complex. 
Structural features of the hairpin loop in the bound RNA 
The seven-residue hairpin loops of all three RNA 
aptamers in the class II family (Z7-mer, Figure lb; 29-mer 
and 36-mer) adopt a common unique conformation on 
complex formation with the bound peptide. The hairpin- 
loop fold is well defined except for two looped-out pyrim- 
idines amongst the refined structures of the 17-mer Rev 
peptide-27-mer RNA aptamer II complex (Figure 5a). 
The loop is closed by a conserved sheared GlZ*A18 mis- 
match pair that was identified on the basis of an NOE 
between the imino proton of G12 and the H8 proton of 
A18, a feature characteristic of sheared G*A mismatch 
alignments [Z&23]. There is extensive stacking between 
the sheared GlZ*A18 mismatch pair and the junctional 
Watson-Crick Al l*U19 base pair in the refined structures 
of the complex. Hydrogen-bonding restraints for the 
sheared GlZ*A18 mismatch pair were incorporated during 
the molecular dynamics computations, but their removal 
at the end of the computations followed by further reline- 
ment did not affect the structure of the bound hairpin 
loop or the number of NOE violations within this 
segment. The G17 base is stacked on the sheared 
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Figure 6 
Views of (a,c,e) eight superpositioned 
refined structures and (b,d,f) one 
representative refined structure with 
emphasis on intermolecular contacts in the 
1 ‘I-mer Rev peptide-27-mer RNA aptamer II 
complex. (a,b) Intermolecular contacts 
involving the sidechains of Trp45 and Arg46 
(yellow) of the Rev peptide and the G14 and 
U 16 bases (cyan) of the RNA aptamer. 
(c,d) intermolecular contacts between the 
peptide backbone (yellow) and the 
Watson-Crick edge of U16 (cyan) and 
between the sidechain of Arg46 (yellow) and 
the phosphate oxygens (orange) at the 
Al 1 -G12-U13 step of the RNA backbone. 
The balls identify donor and acceptor atoms 
involved in potential intermolecular hydrogen- 
bonding interactions. (e,f) Intermolecular 
contacts between the G 10 base (cyan) and 
the sidechain of Arg41 (yellow) positioned 
next to the U@(Al 1 l Ul 9) base triple (green). 
GlZ*AlB mismatch pair and its Watson-Crick edge is 
directed towards the phosphate oxygens of the G12-U13 
step across the loop (Figure Sa,b). This alignment is 
defined by the distribution of intramolecular NOES 
observed between the slowly exchanging imino proton of 
G17 and the sugar protons of the G12-U13-G14 segment 
across the hairpin loop in the complex. The G14 and U16 
hairpin loop bases are better defined than their U13 and 
Cl5 loop counterparts amongst the refined structures of 
the complex (Figure Sa). The G14 base adopts a syn align- 
ment consistent with the strong NOE between the H8 
proton and its own Hl’ proton in short mixing time 
NOESY data of the complex. One such example is the 
nonsequential NOE between the H8 protons of G14 and 
G18 in the NOESY spectrum of the complex. The G14 
and U16 bases are stacked on each other, consistent with 
the observed nonsequential NOE between the H8 proton 
of G14 and the Hl’ proton of U16 in the NOESY spec- 
trum of the complex. The stacked G14 and U16 bases are 
aligned approximately orthogonal to the plane of G17 in 
the complex (Figures Sa,b). Such a relative alignment 
explains the upfield ring current shift of the H8 
(6.64 ppm) and Hl’ (3.86 ppm) protons of G14, which are 
positioned over the aromatic ring of G17 in the complex. 
The well-defined alignment of the G14 and U16 bases 
reflects their participation in intermolecular packing con- 
tacts with peptide residues in the complex (Figures 6a,b). 
By contrast, U13 and C15, which play no role in molecular 
recognition of the bound Rev peptide, are poorly defined 
amongst refined structures of the complex. It is not sur- 
prising, therefore, that U13 in 27-mer RNA aptamer II 
(Figure lb) can be replaced by Al3 in the 36-mer RNA 
aptamer II and that Cl5 in 27-mer RNA aptamer II 
(Figure lb) can be replaced by G15 in the 29-mer RNA 
aptamer II. The residues 13 and 15 are the only two non- 
conserved positions within the seven-residue hairpin 
loops of the three class II RNA aptamers that bind Rev 
peptide with comparable affinity. 
Structural features of the bound Rev peptide 
The 17-mer Rev peptide adopts an extended conforma- 
tion along its entire length when bound to the class II 
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RNA aptamers. This result is consistent with the strong 
intramolecular NOES between Ha(i) and NH(i + 1) 
protons and weak NOES between adjacent amide protons 
in the complex. Further, no continuous NH(i) to 
NH(i + Z), NH(i) to NH(i + 3) and Ha(i) to NH(i + 3) 
NOES characteristic of an a-helical peptide conformation 
were observed for the bound Rev peptide in the complex. 
The Asn40-Arg48 residues represent the best defined 
backbone segment of the bound Rev peptide (Figure 3a) 
in the complex. This is a consequence of the majority of 
the intermolecular NOES originating from this segment 
of the bound peptide as listed in Table 1. The amino acid 
sidechains are poorly defined, except for Trp45 
(Figure Sc,d), amongst the refined structures of the 
complex. The line broadening observed to different 
degrees for protons of several peptide sidechains may 
reflect contributions associated with lack of intramolecu- 
lar hydrogen bonding within the bound peptide, coupled 
with local conformational flexibility of particular 
sidechains of the bound peptide in the complex. 
Peptide-RNA interface in the complex 
The NOE fingerprint patterns characteristic of specific 
complex formation are consistent with the truncated 
15mer Rev (lacking Gln49 and Arg50, and R39A and 
R44N mutations) and 11-mer Rev (lacking Thr34-Arg39, 
and R42A and R43A mutations) peptides binding to the 
same target site on the class II RNA aptamers, as does the 
17-mer Rev peptide. This restricts the minimal core- 
binding domain of Rev to the sequence spanning the 
Asn40-Arg48 segment of the peptide, whereas weak inter- 
molecular NOES approximately position the amino termi- 
nus of the peptide within the major groove of the longer 
stem of the RNA aptamer. Arg42 and Arg43 within the 
core binding region, and Arg39 adjacent to it, do not 
appear to be critical for site-specific recognition because 
replacement by alanine residues does not adversely affect 
complex formation. The same conclusion holds following 
replacement of the longer sidechain of Arg44 by the 
shorter sidechain of asparagine. 
The peptide is anchored within the binding pocket of the 
RNA aptamer through two sets of intermolecular interac- 
tions associated with the core-binding segment of the 
complex. The Trp4.5-Arg48 segment of the Rev peptide 
interacts with the hairpin-loop segment of the RNA 
aptamer (Figure 6a), whereas the sidechain of Arg41 is posi- 
tioned along the major groove edge of the Watson-Crick 
GlO*CZO base pair and adjacent U&(All*U19) base triple 
in the complex (Figure 6~). These intermolecular interac- 
tions in the complex are discussed in further detail below. 
Rev Trp45-U16 RNA stacking interaction 
The mutual alignment of the aromatic rings of Trp45 and 
U16 in the distance-refined structures of the complex 
(Figure 6a) are defined by a large number of intermolecular 
NOES between these two residues in the complex 
(Table 1). The aromatic rings of Trp45 and U16 stack on 
each other (Figure 6b) resulting in the stabilization of the 
bound conformation of the RNA hairpin loop and anchor- 
ing of the carboxyl terminus of the bound Rev peptide in 
the RNA binding pocket. This stacking explains the 
upfield ring current shifted position of the H6 proton of 
U16 (6.80 ppm) in the complex. A related tryptophan-base 
intermolecular van der Waals stacking interaction has been 
reported in the h N-peptide-boxB RNA complex [24-261. 
In this latter case, a tryptophan aromatic ring stacks over an 
adenine ring and in the process extends the characteristic 
stacking associated with the 3’ residues of a GNRA (where 
N is any nucleotide and R is a purine) loop. 
U16 Watson-Crick edge-peptide backbone hydrogen- 
bonding interaction 
The base and sugar protons of U16 exhibit a large number 
of intermolecular NOES to the backbone and/or sidechain 
protons of Trp45, Arg46, Glu47 and Arg48 in the complex 
(Table 1). Specifically, the imino proton of U16 exhibits 
NOES to the backbone amide protons of Arg46, Glu47 and 
Arg48 (Table 1). The relative alignment of the Watson- 
Crick edge of U16 to the peptide backbone between Trp45 
and Arg48 is well defined amongst the distance refined 
structures of the complex (Figure 6~). This alignment is 
stabilized by potential intermolecular hydrogen bonds 
between the amide proton of Arg46 and the 02 carbonyl of 
U16 and between the amide carbonyl of Arg46 and the N3 
of U16 in the complex (Figure 6d). U16 is therefore 
anchored through stacking with Trp45 and by hydrogen 
bonding with the peptide backbone in the complex. 
Arginine-guanine and arginine-backbone interactions 
Our inability to assign the arginine sidechain qNH2 
protons, as well as to identify intermolecular NOES 
between assigned arginine sidechain &NH protons and 
RNA aptamer protons in the NMR data sets on the 
complex, has resulted in poorly defined orientations of the 
arginine sidechain guanidinium groups relative to the 
RNA amongst the refined structures of the complex. This 
leaves us with qualitative conclusions about the orienta- 
tion of the arginine sidechains based on available inter- 
molecular NOES between their nonexchangeable 
methylene protons and RNA aptamer protons in the 
complex (Table 1). The majority of these intermolecular 
NOES involve Arg41, Arg46 and Arg48 (Table l), and 
these residues will be the primary focus of our discussion. 
The sidechain of Arg41 is directed towards the major 
groove edge of GlO of the Watson-Crick GlO*C’ZO pair 
(Figures 6e,f), whereas the sidechain of Arg44 is directed 
towards the major groove edge of GlZ of the sheared 
GlZ*A18 mismatch pair amongst the majority of the 
refined structures of the complex. There are many exam- 
ples in the literature of the guanidinium group of arginine 
aligning through hydrogen-bond formation with the major 
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Figure 7 in the majority of the refined structures of the complex 
(Figures 6c,d). 
Comparison of Rev peptide conformations bound to class I 
and II RNA aptamers 
The solution structure of the 17-mer Rev peptide bound to 
the 35-mer RRE RNA aptamer I (class I, Figure lc) 
reported previously [lo] is shown in Figure 2a. An 
expanded view of the core-binding site is shown in 
Figure 7a. The Rev peptide binds in an a-helical conforma- 
tion [9,10,12] within the major groove centered about adja- 
cent G*A and A*A mismatches. Key intermolecular contacts 
involve hydrogen bonding between the guanidinium 
groups of Arg35 and Arg39 and the major groove edges of 
nonadjacent guanines involved in G*C pair formation and 
between the amide sidechain of Asn40 and both bases in 
the G*A mismatch pair (see also [28]). The complex is sta- 
bilized through formation of a U*(A*U) base triple, which 
serves as a platform for aligning the nonpolar sidechains of 
Arg3.5 and Arg39 involved in arginine-guanine pairing. The 
Rev peptide is bound deep in the major groove, which is 
widened by the presence of two looped out bases, one of 
which originates from the asymmetric internal bubble and 
the other from the two base bulge in the secondary struc- 
ture of 35mer RRE RNA aptamer I (Figure lc). The inter- 
molecular contacts in this complex are summarized 
schematically in Figure 4a. 
Closeup comparative views of the key intermolecular interactions in 
representative refined structures of the complexes of the HIV-1 17-mer 
Rev peptide with (a) the 35smer RRE RNA aptamer I (Figure 1 c) 
reported previously [lo] and (b) the 27-mer RNA aptamer II 
(Figure 1 b) reported in this study. The peptide backbone is yellow and 
the RNA aptamer backbones are white except for phosphorus atoms, 
which are red. The base triples are cyan, base mismatches are pink 
and looped out bases are green. Key intermolecular contacts are 
shown in orange or pink and labeled by residue. 
groove edge of guanine in peptide-RNA complexes 
(reviewed in [27]), including one such interaction with the 
major groove edge of guanine in a sheared G*A mismatch 
pair in the PZ2 N peptide-boxB RNA complex [17]. 
Indeed, the NOE patterns involving the nonexchangeable 
protons of U8 and GlO in the 17-mer Rev peptide-Z7-mer 
RNA aptamer II complex are similar to those previously 
reported for arginine-fork alignments involving arginine- 
guanine-U*(A*U) triple elements in amino acid-RNA 
[19-211 and peptide-RNA [10,17,18] complexes. By con- 
trast, the guanidinium group of Arg46 is directed towards 
adjacent backbone phosphates flanking the G12 residue 
The corresponding solution structure of the 17-mer Rev 
peptide bound to the 27-mer RNA aptamer II (Figure lb) 
determined in this study is shown in Figure 2a and an 
expanded view of the core-binding site shown in 
Figure 7b. The Rev peptide binds in an extended confor- 
mation in the major groove, with the core-binding element 
centered about the hairpin-loop and adjacent short stem 
and two base-bulge segment. The binding-pocket archi- 
tecture is defined, in part, through formation of a U*(A*U) 
triple, the looping out of one base from the two base-bulge 
which forms a flap over a portion of the bound peptide and 
a distinct hairpin-loop conformation closed by a sheared 
G*A mismatch pair. Key intermolecular contacts (summa- 
rized in Figure 4b) involve stacking of the Trp45 sidechain 
against a hairpin loop pyrimidine residue and arginine 
sidechain-guanine major groove edge interactions involv- 
ing Arg41 and Arg44. The extended alignment of the 
bound peptide chain permits adjacent Arg44 and Trp45 
residues to form intermolecular contacts with nonadjacent 
G12 (through hydrogen bonding) and U16 (stacking) RNA 
aptamer residues in the complex (Figure 7b). Similarly, an 
extended bound peptide conformation permits the NH 
and CO groups of Arg46 and the NH group of Arg48 to 
.form intermolecular contacts with the Watson-Crick edge 
of U16 of the RNA aptamer in the complex (Figure 6b). 
These studies establish that the Rev-peptide-binding 
pockets adopt very different architectures in the complexes 
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formed with class I RRE RNA aptamer I (Figure lc) and 
class II RNA aptamer II (Figure lb). The arginine-rich Rev 
peptide binds in an a-helical conformation to class I RRE 
RNA aptamer I (Figures 2a,7a) whereas it binds in an 
extended conformation to class II RNA aptamer II 
(Figures Zb,7b). Further, the bound peptides adopt oppo- 
site directionalities in these two complexes (Figure 2). The 
key specificity-determining amino acids are Arg3.5, Arg39 
and Asn40 in the complex with class I RRE RNA aptamer I 
(Figure 7a) and Arg41, Arg44 and Trp45 in the complex 
with class II RNA aptamer II (Figure 7b). There are no 
intermolecular peptide-backbone-RNA interactions in the 
complex between the bound a-helical Rev peptide and the 
class I RRE RNA aptamer I target [lo], in contrast to the 
observation of such interactions in the complex between 
the bound extended Rev peptide and the class II RNA 
aptamer II target (this study). These structural studies 
establish that short arginine-rich peptides undergo adaptive 
folding transitions, with the diversity of their bound confor- 
mations and the nature of their intermolecular contacts 
correlated with the unique architectures of major-groove- 
binding pockets of distinct RNA scaffolds. 
Comparison of peptide-RNA and protein-RNA complexes 
These conclusions regarding peptide-RNA complexes can 
be contrasted with related structural studies on protein- 
RNA complexes. An interesting example is the bacterio- 
phage MS2 coat protein-RNA system, for which crystal 
structures are available for the coat protein dimer with the 
wild-type RNA [29] and two RNA aptamer complexes 
[30,31]. In this system, it is the protein dimer that retains 
its three-dimensional fold in all three complexes, whereas 
while the RNA components undergo adaptive structural 
transitions on complex formation. A critical feature of the 
MS2 coat protein-RNA system is that specific recognition 
nucleotides on the RNA are inserted into conserved 
hydrophobic binding pockets on the protein surface and 
anchored into position by intermolecular hydrogen 
bonding interactions. Similar observations have been 
made for the complex of Esc~e~%ia co/i glutaminyl tRNA 
synthetase complexed to tRNA(Gln) and ATP [32], and 
recently for the complex of the HIV-Z nucleocapsid 
protein bound to SL3 v-RNA [33]. 
In essence, the two systems under comparison are comple- 
mentary in that in peptide-RNA complexes it is the RNA 
tertiary structure and its binding pockets for minimal ele- 
ments of peptide secondary structure that govern complex 
formation, whereas in protein-RNA complexes it is the 
protein tertiary structure and its binding pockets for 
minimal elements of RNA secondary structure that govern 
complex formation. 
Implications of adaptive binding 
Our results confirm that RNA aptamers can strongly 
induce conformational changes in peptide epitopes, just as 
antipeptide antibodies can undergo adaptive binding with 
their epitopes. These results have implications for both 
the biology of protein-RNA interactions and for drug dis- 
covery. To the extent that different RNA molecules can 
bind different conformations of the same amino-acid 
sequence, it might be possible for a single regulatory 
protein to interact with quite different RNA targets. Simi- 
larly, adaptive binding might allow the same protein-RNA 
interface to exist in multiple forms. For example, it might 
be possible for ribosomal protein arginine-rich motifs 
(ARMS) to remain associated with the translation appara- 
tus during translocation. Finally, to the extent that strong 
interactions between the sequence of a RNA target and 
the chemical moieties present on a peptide or drug can 
drive binding irrespective of backbone conformations, it 
might prove possible to design drugs that can bind to mul- 
tiple, related RNA targets. For example, a RNA-binding 
compound with sufficient affinity for a target sequence 
might still bind even if distal mutations cause the target to 
be presented in a different structural context. If this 
hypothesis continues to hold true, it might even be possi- 
ble to design RNA-binding compounds that to some 
extent anticipate the evolution of resistant variants of viral 
binding elements. Indeed, based on the current example, 
it might be expected that even distantly related variants of 
the Rev-binding element could nonetheless be decoyed 
by an appropriate pharmaceutical peptide. 
Significance 
The solution structures of a limited number of arginine- 
rich basic peptide-RNA complexes have been reported 
to date. The majority of the peptides adopt an a-helical 
conformation (in complexes of the HIV-l regulator of 
viral expression, Rev, with its RNA response element, 
RRE [9,12,34] and with a ‘class I’ RRE aptamer 
[lo], as well as in the complexes of N peptide and boxB 
RNA involved in bacteriophage antitermination in the 
P22 1171 and h [24-261 systems). In the complex of the 
BIV trans.activator protein (Tat) with its RNA 
response element, TAR, Tat adopts a P-sheet conforma- 
tion [18,35]. The peptides are primarily unstructured 
when free in solution and undergo adaptive structural 
transitions to minimal elements of protein secondary 
structure on complex formation 127,361. 
Here we show that in a 17.mer peptide fragment of Rev, 
when bound to a class II RNA aptamer, adopts an 
extended peptide conformation bound within the major 
groove of its RNA target site. This is in sharp contrast to 
the a-helical conformation the same peptide adopts when 
bound to the class I 35.mer RRE RNA aptamer I. These 
results unequivocally demonstrate that an unfolded 
peptide can utilize different folded conformations to recog- 
nize RNA partners with distinct peptide-binding pockets 
(this concept is discussed in [371). This is achieved by 
using different amino-acid sidechains in the recognition 
666 Chemistry & Biology 1999, Vol 6 No 9 
process and establishes the diversity of intermolecular 1H-‘3C HSQC (H,O), three-dimensional CBCA(CO)NH (H,O), three- 
alignments associated with peptide-RNA recognition. dimensional HNCACB (H,O) and three-dimensional C(CO)NH (H,O) 
were recorded on a sample of the complex with uniformly 15N,13C labeled 
Our results experimentally establish that unstructured 
peptides can target multiple RNA partners and, through 
adaptive binding, adopt distinct bound secondary folds at 
the peptide-RNA interface. Adaptive reorganization 
involving one or both partners on peptid*RNA complex 
formation could generate new surface architectures for 
the sequential addition of further components character- 
istic of multimeric systems. 
Materials and methods 
Sample preparation 
The HIV-1 17-mer Rev peptide (Figure 1 a) with a carboxamide protect- 
ing group at the carboxyl terminus and its 15-mer and 11 -mer analogs 
were chemically synthesized and purified using high-performance liquid 
chromatography (HPLC) in the Sloan-Kettering Microchemistry Core 
Facility. The 15N-labeled or 13C,i5N-labeled 1 ‘I-mer Rev peptides were 
obtained by cloning the synthetic gene into a T7 expression plasmid, 
followed by over expressing the gene in E. co/i grown in a medium sup 
plemented either with i5NH,CI or with ‘ENH,CI and 13C-glucose as 
sole nitrogen and carbon sources, respectively. To facilitate purifica- 
tion, the peptide was expressed as a histidine (His) tag fusion protein. 
The expressed protein formed inclusion bodies, which allowed the 
protein to be easily isolated from soluble proteins, and the His tag 
allowed further purification on a nickel chelating column. The desired 
peptide was then cleaved from the fusion protein with cyanogen 
bromide and purified using a Cl6 (Vydac) column by reverse-phase 
HPLC. The Rev-peptide-binding RNA aptamers were synthesized by 
in vitro transcription from a DNA template with commercially available 
NTPs (nucleoside triphosphates) or (‘3C,15N)-labeled NTPs using T7 
RNA polymerase and subsequently purified using gel electrophoresis. 
The peptide-RNA complexes were generated by gradual addition of 
Rev peptide to the RNA aptamers with the stoichiometry monitored by 
following the intensity of the free and bound imino protons of the RNA 
aptamer (in slow exchange) in H,O solution. The concentration of the 
Rev peptide-RNA aptamer complexes ranged between 0.5 and 2 mM. 
NMR data collection and processing 
NMR spectra of the Rev peptide-RNA aptamer complexes in 10 mM 
sodium phosphate buffer at pH 6.2 were acquired on Varian lnova 
500 MHz and 600 MHz NMR spectrometers. Two-dimensional data sets 
were processed with VNMR (Ovarian) and analyzed with FELIX 
(Biosym/MSI). Three-dimensional data sets were processed with 
NMRpipe [38] and analyzed with PIPP [39]. Resonance assignments and 
NOE intensities for the Rev peptide and RNA aptamer components of the 
complexes were obtained from the following NMR experiments: two- 
dimensional NOESY (H,O and D,O), two-dimensional DQ-COSY and 
two-dimensional TOCSY (H,O and D,O) data sets were recorded on 
unlabeled samples of the complexes containing various combinations of 
Rev peptides and RNA aptamers. Two-dimensional lH-j5N HSQC (H,O), 
two-dimensional I H-‘3C HSQC (D,O), two-dimensional 15N-edited 
HMQC-NOESY (H,O), three-dimensional HCCH-COSY (D,O), three- 
dimensional HCCH-TOCSY (D,O) and three-dimensional %-edited 
NOESY-HMQC (D,O) data sets were recorded on a sample of the 
complex containing uniformly 13C,15N-labeled 27-mer RNA aptamer-II and 
unlabeled 17-mer Rev peptide. Two-dimensional lH-T5N HSQC (H,O), 
three-dimensional ‘5N-edited HMQC-NOESY (H,O) and three-dimen- 
sional 15N-edited HMQC-TOCSY (H,O) were acquired on a sample of 
the complex with uniformly 15N-labeled 17-mer Rev peptide and unla- 
beled 27-mer RNA aptamer II. Two-dimensional lH-15N HSQC (H,O) 
and two-dimensional ’ H-13C HMQC-NOESY (H,O) were collected on a 
sample of the complex with selectively 15N,‘3C labeled 17-mer Rev 
peptide (labeled at Arg41 and Arg46) and unlabeled 27-mer RNA 
aptamer Il. Two-dimensional lH-15N HSCIC (H,O), two-dimensional 
1 ‘I-mer Rev peptide and‘unlabeled 27-mer RNA aptam&-Il. Proton chem- 
ical shifts were referenced to 2,2-dimethyl-2-silapentane-5-sulfonate 
(DSS), whereas carbon and nitrogen chemical shifts were referenced to 
DSS and ammonia, respectively. 
Distance restraints 
Interproton distance restraints were obtained from NOE cross-peak 
volumes in two-dimensional NOESY and three-dimensional NOESY- 
HMQC data sets with the corresponding distance bounds calibrated 
using pyrimidine H5-H6 as a reference distance. The NOESY data 
sets were collected at various mixing time ranging from 80 ms to 
300 ms. The distance bounds for restraints obtained from three-dimen- 
sional NOESY-HMQC (120 ms mixing time) spectra in D,O or H,O 
buffer and two-dimensional NOESY (100 and 150 ms mixing time) in 
H,O or D,O buffer were cate orized as strong (2.5 8, f 0.7), medium 
(3.5 A f 1.0) or weak (4.5 f 1.5). The corresponding distance 81 
bounds were increased for restraints obtained from NOESY (mixing 
time > 150 ms) spectra in D,O buffer and those involving more rapidly 
exchanging protons from NOESY spectra in H,O buffer, which were 
cate orized as strong (2.7 A* l.O), medium (3.5Af 1.5), and weak 
(4.5 1 f 2.0). Larger distance bounds were also used for NOES involv- 
ing methyl-group protons. 
Torsion-angle restraints of the endocyclic torsion angles within ribose 
sugars of RNA were obtained from an analysis of COSY experiments. 
The furanose rings with strong Hl’-H2’ cross peaks were restricted to 
C2’-endo (P= 144-180’) sugar puckers, whereas those rings that 
showed no HI’-HP’ cross peaks were restricted to C3’-endo 
(P = O-36’) sugar puckers. These sugar pucker pseudorotation angles 
were next translated to corresponding values and ranges for the sugar 
endocyclic torsion angles. 
Molecular dynamics protocol 
A molecular dynamics-simulated annealing protocol driven by NOE dis- 
tance and dihedral restraints (X-PLOR package, version 3.8, [40]) was 
used to solve the solution structure of the HIV-1 Rev peptide-RNA 
aptamer complex. The refinement procedure include 60 simulated 
annealing trials starting from 60 random-chain conformations for both 
peptide and RNA chains with the components placed 100 A apart in 
space. The dynamics protocol was undertaken in two stages. The first 
stage involved high-temperature molecular dynamics in torsional space. 
The molecules were equilibrated at 20,000 K (15,000 steps over 
1.5 ps) and then cooled slowly to 1,000 K (30,000 steps over 15 ps). 
Nonbonded interactions were restricted to repulsive force field poten- 
tials and these first stage computations were guided by NOE distance 
and dihedral restraints. The second stage involved lower temperature 
dynamics in Cartesian space using Lennard-Jones potentials for van 
der Waals interactions and guided by NOE distance and dihedral 
restraints. The structures were slowly cooled to 300 K (30,000 steps 
over 15 ps) and minimized until the gradient of energy was less than 
0.1 kcal mol-I. The helical stem extending from Gl-C6 and from 
G22-C27 located outside the core-binding region was restrained to an 
A-form helix through incorporation of torsion and hydrogen bonding 
restraints during both high- and low-temperature dynamics. In addition, 
G12 and Al 8 were restricted to the experimentally identified sheared 
G12*A18 mismatch alignment during the computations. The force con- 
stants for NOE distance restraints were maintained at 30 kcal mol-l 
and for dihedral restraints at 25 kcal rad-2. A subset of 22 refined struc- 
tures (~15 kcal mol-’ variation of total energy within the subset) were 
selected based on lowest NOE violation energy and were separated by 
a gap of =250 kcal mol-’ of total energy from the rest of the ensemble. 
Structure analysis 
The RNA helical parameters were analyzed using the CURVES 
program [411. Color figures were prepared using INSIGHT II (Molecu- 
lar Simulations, Inc) program. 
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Accession numbers 
The coordinates of the HIV-1 17-mer Rev peptide-27-mer RNA 
aptamer II complex (accession number: 484d) have been deposited 
with the Protein Data Bank. 
Supplementary material 
Supplementary material including NMR resonance assignments is 
available at http://current-biology.com/supmat/supmatin.htm. 
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